WSWeizhong Sun

Weizhong Sun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Weizhong Sun has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Diff-SelfA-PepGSI: A Diffusion-Based Framework for De Novo Generation, Screening, and Morphological Identification of Self-Assembled Peptide Sequences

    by Weizhong Sun, Yuning Ma, Xiumin Shi, Mingshan Wei, Ao He, Weizhi Wang

    Peptide self-assembly is a ubiquitous molecular phenomenon in which short amino acid sequences spontaneously organize into diverse nanostructures. These assemblies exhibit distinct morphologies closely linked to their biological functions and potential applications, making them attractive candidates for biomaterials in drug delivery, regenerative medicine, and diagnostics. However, designing and predicting peptide sequences with specific self-assembled morphologies remains highly challenging due to the complex interplay of noncovalent interactions, including hydrogen bonding, hydrophobic effects, and π–π stacking. Although deep learning has enabled accurate prediction of peptide self-assembly propensity, rational de novo design of peptides with targeted assembly behavior remains largely unexplored. In this study, we propose Diff-SelfA-PepGSI, a novel pipeline for the morphology-specific design of self-assembling peptides. This three-stage framework comprises: (i) generation, in which a diffusion-based generative model produces candidate self-assembling peptide sequences; (ii) screening, in which pretrained protein language models extract deep semantic features and a deep discriminative network performs sequence optimization and property screening; and (iii) identification, in which a dual-branch structure extracts features and a dedicated classifier identifies the specific nanostructures formed. By integrating sequence generation, predictive screening, and morphology identification, this workflow establishes a proof-of-concept de novo design pipeline that links peptide sequences directly to their target morphologies. Diff-SelfA-PepGSI demonstrates superior performance compared to state-of-the-art models in both screening and identification tasks. Experimental validation preliminarily demonstrates the feasibility of the de novo design pipeline, successfully generating self-assembling peptides such as LAPFLA. Under the reported experimental conditions, 4 of 11 generated candidates (36.4%) exhibited the target morphology predicted by the model. Within the challenging context of de novo morphology-specific peptide design, this success rate supports the potential of Diff-SelfA-PepGSI as an early stage self-assembling peptide generation platform.

  • AbEgDiffuser: Antibody Sequence-Structure Codesign with Equivariant Graph Neural Networks and Diffusion Models

    by Yibo Zhu, Xiumin Shi, Jingjuan Zhang, Weizhong Sun, Lu Wang

    Antibodies are crucial immune proteins with high antigen specificity. Conventional antibody engineering is time-consuming and inefficient, whereas deep learning-driven specific antibody design offers an innovative avenue for drug discovery. In this work, we introduce AbEgDiffuser, a deep generative framework that enables the codesign of antibody sequences and structures conditioned on target antigens. Our model integrates diffusion models with equivariant graph neural networks and further incorporates evolutionary constraints. During forward diffusion, amino acid sequences, Cα atom coordinates, and residue orientations are progressively corrupted toward a prior distribution. In reverse, a bilevel equivariant graph neural network captures both residue- and atom-level interactions to reconstruct functional antibodies. To enforce evolutionary plausibility, we encode noisy sequences with the pretrained protein language model ESM-2. Extensive experiments on de novo antibody design and optimization tasks demonstrate that the model generates antibodies with accurate sequences and structures, as well as high binding affinity, outperforming existing design methods.